Michal Shteinberg Selected Research

Michal Shteinberg Research Topics

Disease

20	Bronchiectasis 04/2024 - 11/2012
17	Cystic Fibrosis (Mucoviscidosis) 11/2023 - 11/2012
11	Infections 12/2023 - 04/2012
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 05/2009
5	Lung Diseases (Lung Disease) 04/2024 - 09/2016
4	Pseudomonas Infections 05/2023 - 01/2017
2	Hypersensitivity (Allergy) 01/2024 - 01/2007
2	Inflammation (Inflammations) 12/2023 - 05/2023
2	Exocrine Pancreatic Insufficiency 01/2023 - 01/2017
2	Bronchiolitis Obliterans Syndrome 09/2016 - 11/2012
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Asthma (Bronchial Asthma) 02/2024
1	Disease Progression 05/2023
1	Cataract (Cataracts) 11/2022
1	COVID-19 01/2022
1	Fatigue 10/2021
1	Cough 10/2021
1	Thrombocytosis (Thrombocythemia) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Necrosis 01/2019
1	Allergic Bronchopulmonary Aspergillosis 01/2019
1	Dysbiosis 01/2019
1	Intestinal Fistula 01/2017
1	Diffuse panbronchiolitis 09/2016
1	Persistent Infection 01/2015
1	Morbid Obesity 08/2012
1	Heart Failure 01/2007
1	Galactorrhea 09/2003

Drug/Important Bio-Agent (IBA)

12	EmbarcIBA 04/2024 - 01/2016
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 11/2012
3	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2023 - 01/2023
3	ivacaftorIBA 11/2022 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 05/2024 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 07/2018
2	insulin receptor-related receptor (IRR)IBA 01/2024 - 01/2023
2	ivacaftor drug combination tezacaftorIBA 11/2023 - 11/2022
2	elexacaftorIBA 11/2023 - 11/2022
2	MacrolidesIBA 05/2023 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 05/2009
2	HaptoglobinsIBA 01/2019 - 12/2015
1	Methacholine Chloride (Methacholine)FDA Link 01/2024
1	CytokinesIBA 01/2024
1	Immunoglobulin E (IgE)IBA 01/2024
1	Serine Proteases (Serine Protease)IBA 05/2023
1	Cathepsin CIBA 05/2023
1	lumacaftorIBA 10/2022
1	Particulate MatterIBA 01/2022
1	SmokeIBA 10/2021
1	vedolizumabIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2019
1	GuanineIBA 01/2017
1	Poly TIBA 01/2017
1	ThymidineIBA 01/2017
1	ChloridesIBA 01/2017
1	Azithromycin (Zithromax)FDA LinkGeneric 09/2016
1	Erythromycin (Erycette)FDA LinkGeneric 09/2016
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2016
1	Heme (Haem)IBA 12/2015
1	Protein Isoforms (Isoforms)IBA 12/2015
1	IronIBA 12/2015
1	Chelating AgentsIBA 12/2015
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2014
1	FluoroquinolonesIBA 11/2012
1	Ampicillin (Omnipen)FDA LinkGeneric 04/2012
1	Furosemide (Lasix)FDA LinkGeneric 01/2007
1	Immunoglobulin G (IgG)IBA 09/2003

Therapy/Procedure

7	Therapeutics 05/2023 - 01/2007
2	Continuous Positive Airway Pressure 01/2021 - 05/2009
2	Lung Transplantation 03/2020 - 09/2016
1	Mammaplasty (Breast Reconstruction) 04/2024
1	Mastectomy (Mammectomy) 04/2024
1	Nebulizers and Vaporizers (Inhaler) 01/2024
1	Precision Medicine 12/2023
1	Aftercare (After-Treatment) 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2021
1	Traction 01/2019
1	Ileostomy 01/2017
1	Treatment Delay 11/2016
1	Operative Surgical Procedures 08/2012